1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  6. Summary
    ALNEV   FR00140077X1


Quotes 5-day view   Real-time Quote. Real-time Euronext Paris
05/16/2022 05/17/2022 05/18/2022 05/19/2022 05/20/2022 Date
0.2384(c) 0.2254(c) 0.2168(c) 0.211(c) 0.2119(c) Last
146 508 213 513 387 213 115 101 228 432 Volume
-2.30% -5.45% -3.82% -2.68% +0.43% Change
More quotes
Estimated financial data (e)
Sales 2019
Net income 2019
Net Debt 2019
P/E ratio 2019
Yield 2019
Sales 2020 0,03 M 0,03 M 0,03 M
Net income 2020 -6,14 M -6,48 M -6,48 M
Net cash position 2020 9,68 M 10,2 M 10,2 M
P/E ratio 2020 -3,31x
Yield 2020 -
Capitalization 0,42 M 0,45 M 0,45 M
EV / Sales 2019
EV / Sales 2020 -137x
Nbr of Employees 18
Free-Float 100,0%
More Financials
NEOVACS has become a major player in the therapeutic vaccines for the treatment of autoimmune and / or inflammatory diseases. With its innovative technology inducing a polyclonal immune response, protected by four patent families potentially until 2038, NEOVACS focuses its clinical efforts on the development of IFN?-Kinoid for treating lupus. The group also carries out preclinical work on other therapeutic vaccines... 
More about the company
All news about NEOVACS
05/02Neovacs S.A. Reports Earnings Results for the Full Year Ended December 31, 2021
03/03NETRI announced that it has received €8 million in funding from Neovacs S.A., and ..
02/09Medical Devices Venture S.A. announced that it has received €2.3 million in fundin..
02/08Medical Devices Venture S.A. announced that it expects to receive €2.3 million in ..
02/01NEOVACS S.A. : REVERSE SPLIT: 1 of 10000
2021NEOVACS : Monthly statement on outstanding equity shares and voting rights
2021GLOBAL MARKETS LIVE : Hermès, Walt Disney, Apple, Novartis, Square...
2021GLOBAL MARKETS LIVE : Merck, Volkswagen, Salesforce, Roche, Mondelez...
2021GLOBAL MARKETS LIVE : Tencent, Vivo Energy, AT&T, Verizon, Petrobras...
2021Neovacs S.A. Reports Earnings Results for the Half Year Ended June 30, 2021
2021Signia Therapeutics SAS announced that it has received ?1.3 million in funding from Neo..
2021GLOBAL MARKETS LIVE : Valneva, Glencore, Facebook, Roche, Hertz...
2021Neovacs S.A. announced that it has received €2 million in funding from L1 Capital Pty. ..
2021GLOBAL MARKETS LIVE : Intel, Apple, Rolls-Royce, Raytheon, MGM...
2021Bio Detection K9 announced that it has received $5 million in funding from Neovacs S.A.
More news
News in other languages on NEOVACS
05/03Gros doigt et compte à rebours
05/03EN DIRECT DES MARCHES : BNP Paribas, Engie, Logitech, Norsk Hydro, Vallourec, Citigroup, A..
05/02Néovacs S.A. annonce ses résultats pour l'année complète se terminant le 31 décembre 20..
05/02NEOVACS : Changement de dimension réussi à l’issue de l’exercice 2021
04/06Dura Lex, Fed Lex
More news
Duration : Period :
NEOVACS Technical Analysis Chart | ALNEV | FR00140077X1 | MarketScreener
Technical analysis trends NEOVACS
Short TermMid-TermLong Term
Income Statement Evolution
Managers and Directors
Hugo Brugière Chairman & Chief Executive Officer
Alexandre Courtoux Director-Finance & Administrative
Vincent Serra Chief Operations & Scientific Officer
Daniel Zagury Director
Jean-Jacques Bertrand Director
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-43.55%57 031
LONZA GROUP AG-29.91%40 761
IQVIA HOLDINGS INC.-28.50%38 185
SEAGEN INC.-7.74%26 255